BARCLAY A PHILLIPS
CIK 1265801 · SVP & Chief Financial Officer · last filed 2025-06-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$343.4K
Companies
5
Total Filings
43
Lifetime Open-Market Net
-$7.70M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IMUX | Director | — | $13.86 | — | $0 | 8 | 2025-06-09 |
| G1 Therapeutics, Inc. (GTHX) Delisted | SVP & Chief Financial Officer | 5,000 | $7.15 | $35.8K | -$199.6K | 3 | 2019-01-02 |
| NVAX | SVP, Chief Financial Officer | 38,669 | $8.88 | $343.4K | -$167.1K | 19 | 2017-08-01 |
| MICROMET, INC. (MITI) Delisted | SVP, CFO | 0 | — | — | -$213.6K | 9 | 2012-03-06 |
| Acorda Therapeutics, Inc. (ACOR) Delisted | Director | 333,419 | $0.66 | $220.4K | -$7.12M | 3 | 2008-06-16 |
Recent Filings · Page 3 of 5
43 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-03-09 | NVAX | Grant (A) | — | $0 | EDGAR |
| 2015-02-03 | NVAX | Buy (P) | +8,388 | $19.1K | EDGAR |
| 2014-10-06 | NVAX | Buy (P) | +5,000 | $20.5K | EDGAR |
| 2014-08-04 | NVAX | Buy (P) | +8,788 | $20.0K | EDGAR |
| 2014-03-25 | NVAX | Buy (P) | +5,000 | $21.2K | EDGAR |
| 2014-03-25 | NVAX | Buy (P) | −5,000 | -$21.2K | EDGAR |
| 2014-03-07 | NVAX | Grant (A) | — | $0 | EDGAR |
| 2014-02-04 | NVAX | Buy (P) | +9,868 | $22.6K | EDGAR |
| 2013-07-05 | NVAX | Buy (P) | — | $0 | EDGAR |
| 2013-07-03 | NVAX | Buy (P) | +50,000 | $95.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.